Deepika Sirohi

1.6k total citations
57 papers, 696 citations indexed

About

Deepika Sirohi is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Cancer Research. According to data from OpenAlex, Deepika Sirohi has authored 57 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Pulmonary and Respiratory Medicine, 19 papers in Molecular Biology and 16 papers in Cancer Research. Recurrent topics in Deepika Sirohi's work include Prostate Cancer Treatment and Research (18 papers), Renal cell carcinoma treatment (14 papers) and Renal and related cancers (12 papers). Deepika Sirohi is often cited by papers focused on Prostate Cancer Treatment and Research (18 papers), Renal cell carcinoma treatment (14 papers) and Renal and related cancers (12 papers). Deepika Sirohi collaborates with scholars based in United States, Japan and Italy. Deepika Sirohi's co-authors include Mahul B. Amin, Steven C. Smith, Neeraj Agarwal, Gladell P. Paner, Antonio López-Beltrán, Benjamin L. Maughan, Daniel Luthringer, Chisato Ohe, Maria Luisa Policarpio‐Nicolas and Rohit Mehra and has published in prestigious journals such as Journal of Clinical Oncology, Annals of Internal Medicine and PLoS ONE.

In The Last Decade

Deepika Sirohi

53 papers receiving 686 citations

Peers

Deepika Sirohi
Matthew J. Wasco United States
Bruno Grilli Switzerland
Michelle Herzog Switzerland
Brett Delahunt New Zealand
Georg E. Feichter Switzerland
Scott R. Gerst United States
Deepika Sirohi
Citations per year, relative to Deepika Sirohi Deepika Sirohi (= 1×) peers Ernesto Rossi

Countries citing papers authored by Deepika Sirohi

Since Specialization
Citations

This map shows the geographic impact of Deepika Sirohi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deepika Sirohi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deepika Sirohi more than expected).

Fields of papers citing papers by Deepika Sirohi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deepika Sirohi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deepika Sirohi. The network helps show where Deepika Sirohi may publish in the future.

Co-authorship network of co-authors of Deepika Sirohi

This figure shows the co-authorship network connecting the top 25 collaborators of Deepika Sirohi. A scholar is included among the top collaborators of Deepika Sirohi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deepika Sirohi. Deepika Sirohi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Chan, Emily, Bradley A. Stohr, Ankur R. Sangoi, & Deepika Sirohi. (2025). Invasive urothelial carcinoma with chordoid and myxoid features shows increased RAS/RAF pathway alterations. Human Pathology. 163. 105882–105882. 1 indexed citations
2.
Tabriz, Amir Alishahi, Matthew J. Boyer, Adelaide M. Gordon, et al.. (2025). Impact of Genomic Classifiers on Risk Stratification and Treatment Intensity in Patients With Localized Prostate Cancer. Annals of Internal Medicine. 178(2). 218–228. 3 indexed citations
3.
Davidson, Christian J., et al.. (2024). EGFR/CEP7 high polysomy is separate and distinct from EGFR amplification in glioblastoma as determined by fluorescence in situ hybridization. Journal of Neuropathology & Experimental Neurology. 83(5). 338–344. 1 indexed citations
4.
Barry, Marc, et al.. (2024). Genotype Phenotype Correlation of Renal Tumors in the Cancer Genome Atlas Database. International Journal of Surgical Pathology. 33(2). 289–301.
5.
Boyer, Matthew J., David Carpenter, Jeffrey R. Gingrich, et al.. (2024). Genomic classifiers and prognosis of localized prostate cancer: a systematic review. Prostate Cancer and Prostatic Diseases. 28(1). 103–111. 5 indexed citations
6.
Schwartz, Christopher J., Gregory R. Bean, Deepika Sirohi, et al.. (2023). Triple-Negative Apocrine Carcinomas: Toward a Unified Group With Shared Molecular Features and Clinical Behavior. Modern Pathology. 36(5). 100125–100125. 14 indexed citations
8.
Swami, Umang, Nicolas Sayegh, Yeonjung Jo, et al.. (2022). External Validation of Association of Baseline Circulating Tumor Cell Counts with Survival Outcomes in Men with Metastatic Castration-Sensitive Prostate Cancer. Molecular Cancer Therapeutics. 21(12). 1857–1861. 5 indexed citations
9.
Winter, Jacob M., Corey N. Cunningham, Heather R. Keys, et al.. (2022). Collateral deletion of the mitochondrial AAA+ ATPase ATAD1 sensitizes cancer cells to proteasome dysfunction. eLife. 11. 10 indexed citations
10.
McFarland, Taylor Ryan, Vinay Mathew Thomas, Roberto Nussenzveig, et al.. (2022). Detection of BRCA1, and BRCA2 Alterations in Matched Tumor Tissue and Circulating Cell-Free DNA in Patients with Prostate Cancer in a Real-World Setting. Biomedicines. 10(12). 3170–3170. 2 indexed citations
11.
Ferreira, Maria Carolina, Daniel G. Fuja, Alexandre Rosa Campos, et al.. (2022). ISCA2 inhibition decreases HIF and induces ferroptosis in clear cell renal carcinoma. Oncogene. 41(42). 4709–4723. 46 indexed citations
12.
Tripathi, Nishita, Yeonjung Jo, Abhishek Tripathi, et al.. (2022). Genomic landscape of locally advanced or metastatic urothelial carcinoma with squamous differentiation compared to pure urothelial carcinoma. Urologic Oncology Seminars and Original Investigations. 40(11). 493.e1–493.e7. 4 indexed citations
13.
Lin, Edwin, Andrew W. Hahn, Roberto Nussenzveig, et al.. (2021). Identification of Somatic Gene Signatures in Circulating Cell-Free DNA Associated with Disease Progression in Metastatic Prostate Cancer by a Novel Machine Learning Platform. The Oncologist. 26(9). 751–760. 11 indexed citations
15.
Lin, Leo, Deepika Sirohi, Joshua F. Coleman, & H. Evin Gulbahce. (2019). American Society of Clinical Oncology/College of American Pathologists 2018 Focused Update of Breast Cancer HER2 FISH Testing GuidelinesResults From a National Reference Laboratory. American Journal of Clinical Pathology. 152(4). 479–485. 27 indexed citations
16.
Sirohi, Deepika, Patrick Devine, James P. Grenert, et al.. (2019). TP53 structural variants in metastatic prostatic carcinoma. PLoS ONE. 14(6). e0218618–e0218618. 13 indexed citations
17.
Li, Ping, Sungyong You, Christopher Nguyen, et al.. (2018). Genes involved in prostate cancer progression determine MRI visibility. Theranostics. 8(7). 1752–1765. 54 indexed citations
18.
Sirohi, Deepika, Steven C. Smith, Jonathan I. Epstein, et al.. (2017). Pericytic tumors of the kidney—a clinicopathologic analysis of 17 cases. Human Pathology. 64. 106–117. 12 indexed citations
19.
Kuroda, Naoto, Chisato Ohe, Deepika Sirohi, et al.. (2016). Review of renal anastomosing hemangioma with focus on clinical and pathological aspects. Polish Journal of Pathology. 2(2). 97–101. 2 indexed citations
20.
Paner, Gladell P., Antonio López-Beltrán, Deepika Sirohi, & Mahul B. Amin. (2016). Updates in the Pathologic Diagnosis and Classification of Epithelial Neoplasms of Urachal Origin. Advances in Anatomic Pathology. 23(2). 71–83. 59 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026